Sign in
4

Changes in Ownership

Camp4 Therapeutics Corp Filed Acc 0001628280-26-060234

Chief Financial Officer bought 10,000 shares at $3.96 ($39,600)

From the SEC's structured data for this filing

Trades in this filing

Gold Kelly · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-08-31 Purchase : show line 1 in the form +10,000 $3.96 $39,600 10,000 I
Open-market purchases · 10,000 sh · avg $3.96 · $39,600
Loading xslF345X06/wk-form4_1788393010.xml…